Antiobesity effects of a–lipoic acid supplementation

References

• Reed LJ, De BB, Gunsalus IC, Hornberger CS Jr. Crystalline a-lipoic acid; a catalytic agent associated with pyruvate dehydrogenase. Science 93–94 (1951).
   Google Scholar
• Packer L, Kraemer K, Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 17, 888–895 (2001).
   Google Scholar
• Packer L, Witt EH, Tritschler HJ. a-lipoic acid as a biological antioxidant. Free Radic. Biol. Med. 19, 227–250 (1995).
   Google Scholar
• Morikawa T, Yasuno R, Wada H. Do mammalian cells synthesize lipoic acid? Identification of a mouse cDNA encoding a lipoic acid synthase located in mitochondria. FEBS Lett. 498, 16–21 (2001).
   Google Scholar
• Streeper RS, Henriksen EJ, Jacob S et al. Differential effects of lipoic acid stereoisomers on glucose metabolism in insulin-resistant skeletal muscle. Am. J. Physiol. 273, e185–e191 (1997).
   Google Scholar
• Yaworsky K, Somwar R, Ramlal T, Tritschler HJ, Klip A. Engagement of the insulinsensitive pathway in the stimulation of glucose transport by a-lipoic acid in 3T3-L1 adipocytes. Diabetologia 43, 294–303 (2000).
   Google Scholar
• Moini H, Tirosh O, Park YC, Cho KJ, Packer L. R-a-lipoic acid action on cell redox status, the insulin receptor, and glucose uptake in 3T3-L1 adipocytes. Arch. Biochem. Biophys. 397, 384–391 (2002).
   Google Scholar
• Suh JH, Shenvi SV, Dixon BM et al. Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc. Natl Acad. Sci. USA 101, 3381–3386 (2004).
   Google Scholar
• Suh JH, Moreau R, Heath SH, Hagen TM. Dietary supplementation with (R)-a-lipoic acid reverses the age-related accumulation of iron and depletion of antioxidants in the rat cerebral cortex. Redox Rep. 10, 52–60 (2005).
   Google Scholar
• De Araujo DP, Lobato Rde F, Cavalcanti JR et al. The contributions of antioxidant activity of lipoic acid in reducing neurogenerative progression of Parkinson’s disease: a review. Int. J. Neurosci. 121, 51–57 (2011).
   Google Scholar
• Arivazhagan P, Ramanathan K, Panneerselvam C. Effect of DL-a-lipoic acid on glutathione metabolic enzymes in aged rats. Exp. Gerontol. 37, 81–87 (2001).
   Google Scholar
• Yadav V, Shinto L, Bourdette D. Complementary and alternative medicine for the treatment of multiple sclerosis. Expert Rev. Clin. Immunol. 6, 381–395 (2012).
   Google Scholar
• Xiang G, Pu J, Yue L, Hou J, Sun H. a-lipoic acid can improve endothelial dysfunction in subjects with impaired fasting glucose. Metabolism 60, 480–485 (2011).
   Google Scholar
• Kanter M, Sen S, Donmez S et al. Protective effects of irbesartan and a lipoic acid in STZinduced diabetic nephropathy in rats. Ren. Fail. 32, 498–505 (2010).
   Google Scholar
• Nanayakkara PW, Gaillard CA. Vascular disease and chronic renal failure: new insights. Neth. J. Med. 68, 5–14 (2010).
   Google Scholar
• Shay KP, Moreau RF, Smith EJ, Smith AR, Hagen TM. a-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim. Biophys. Acta 1790, 1149–1160 (2009).
   Google Scholar
• Holdsworth M, El Ati J, Bour A et al. Developing national obesity policy in middleincome countries: a case study from North Africa. Health Policy Plan doi:10.1093/heapol/czs125 (2012) (Epub ahead of print).
   Google Scholar
• Manco M, Dallapiccola B. Genetics of pediatric obesity. Pediatrics 130, 123–133 (2012).
   Google Scholar
• Mathieu P, Lemieux I, Despres JP. Obesity, inflammation, and cardiovascular risk. Clin. Pharmacol. Ther. 87, 407–416 (2010).
   Google Scholar
• Prieto-Hontoria PL, Perez-Matute P, Fernandez-Galilea M et al. Role of obesity-associated dysfunctional adipose tissue in cancer: a molecular nutrition approach. Biochim. Biophys. Acta 1807, 664–678 (2011).
   Google Scholar
• Simonyi G, Pados G, Medvegy M, Bedros JR. The pharmacological treatment of obesity: past, present and future. Orv. Hetil. 153, 363–373 (2012).
   Google Scholar
• Picklo M, Claycombe KJ, Meydani M. Adipose dysfunction, interaction of reactive oxygen species, and inflammation. Adv. Nutr. 3, 734–735 (2012).
   Google Scholar
• Bryan S, Baregzay B, Spicer D, Singal PK, Khaper N. Redox-inflammatory synergy in the metabolic syndrome. Can. J. Physiol. Pharmacol. 91, 22–30 (2013).
   Google Scholar
• Kim MS, Park JY, Namkoong C et al. Antiobesity effects of a-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat. Med. 10, 727–733 (2004). Describes, for the first time, that the antiobesity and anorexigenic effects of a-lipoic acid (a-LA) supplementation in rodents are mediated by suppression of hypothalamic AMP kinase activity.
   Google Scholar
• Song KH, Lee WJ, Koh JM et al. a-lipoic acid prevents diabetes mellitus in diabetesprone obese rats. Biochem. Biophys. Res. Commun. 326, 197–202 (2005).
   Google Scholar
• Butler JA, Hagen TM, Moreau R. Lipoic acid improves hypertriglyceridemia by stimulating triacylglycerol clearance and downregulating liver triacylglycerol secretion. Arch. Biochem. Biophys. 485, 63–71 (2009).
   Google Scholar
• Prieto-Hontoria PL, Perez-Matute P, Fernandez-Galilea M et al. Lipoic acid prevents body weight gain induced by a high-fat diet in rats: effects on intestinal sugar transport. J. Physiol. Biochem. 65, 43–50 (2009).
   Google Scholar
• Timmers S, de Vogel-van den Bosch J, Towler MC et al. Prevention of high-fat diet-induced muscular lipid accumulation in rats by a lipoic acid is not mediated by AMPK activation. J. Lipid Res. 51, 352–359 (2010).
   Google Scholar
• Chen WL, Kang CH, Wang SG, Lee HM. a-lipoic acid regulates lipid metabolism through induction of sirtuin 1 (SIRT1) and activation of AMP-activated protein kinase. Diabetologia 55, 1824–1835 (2012). Demonstrated that a-LA increases b-oxidation and decreases triacylglycerol accumulation through induction of SIRT1 and AMP kinase in myotubes.
   Google Scholar
• Mathews CE, Bagley R, Leiter EH. ALS/Lt: a new Type 2 diabetes mouse model associated with low free radical scavenging potential. Diabetes 53(Suppl. 1), S125–S129 (2004).
   Google Scholar
• Cheng PY, Lee YM, Yen MH, Peng JC, Lam KK. Reciprocal effects of a-lipoic acid on adenosine monophosphate-activated protein kinase activity in obesity induced by ovariectomy in rats. Menopause 18, 1010–1017 (2011).
   Google Scholar
• Banday AA, Fazili FR, Marwaha A, Lokhandwala MF. Mitogen-activated protein kinase upregulation reduces renal D1 receptor affinity and G-protein coupling in obese rats. Kidney Int. 71, 397–406 (2007).
   Google Scholar
• Cummings BP, Stanhope KL, Graham JL et al. Dietary fructose accelerates the development of diabetes in UCD-T2DM rats: amelioration by the antioxidant, a-lipoic acid. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R1343–R1350 (2010).
   Google Scholar
• Muellenbach EM, Diehl CJ, Teachey MK et al. Metabolic interactions of AGE inhibitor pyridoxamine and antioxidant a-lipoic acid following 22 weeks of treatment in obese Zucker rats. Life Sci. 84, 563–568 (2009).
   Google Scholar
• Saengsirisuwan V, Perez FR, Sloniger JA, Maier T, Henriksen EJ. Interactions of exercise training and a-lipoic acid on insulin signaling in skeletal muscle of obese zucker rats. Am. J. Physiol. Endocrinol. Metab. 287, e529–e536 (2004).
   Google Scholar
• Kim E, Park DW, Choi SH, Kim JJ, Cho HS. A preliminary investigation of a-lipoic acid treatment of antipsychotic drug-induced weight gain in patients with schizophrenia. J. Clin. Psychopharmacol. 28, 138–146 (2008).
   Google Scholar
• Carbonelli MG, Di Renzo L, Bigioni M et al.a-lipoic acid supplementation: a tool for obesity therapy? Curr. Pharm. Des. 16, 840–846 (2010). Describes, for the first time, the antiobesity properties of a-LA supplementation in obese healthy humans.
   Google Scholar
• Koh EH, Lee WJ, Lee SA et al. Effects of a-lipoic acid on body weight in obese subjects. Am. J. Med. 124, 85 e81–e88 (2011). Suggests that a-LA may be considered as adjunctive therapy for promoting weight loss in combination with energy-restricted diets in humans.
   Google Scholar
• McNeilly AM, Davison GW, Murphy MH et al. Effect of a-lipoic acid and exercise training on cardiovascular disease risk in obesity with impaired glucose tolerance. Lipids Health Dis. 10, 217 (2011).
   Google Scholar
• Zhang Y, Han P, Wu N et al. Amelioration of lipid abnormalities by a-lipoic acid through antioxidative and anti-inflammatory effects. Obesity (Silver Spring) 19, 1647–1653 (2011).
   Google Scholar
• Stark R, Ashley SE, Andrews ZB. AMPK and the neuroendocrine regulation of appetite and energy expenditure. Mol. Cell. Endocrinol. 366, 215–223 (2013).
   Google Scholar
• Wang Y, Li X, Guo Y, Chan L, Guan X. a-lipoic acid increases energy expenditure by enhancing adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor-g coactivator-1a signaling in the skeletal muscle of aged mice. Metabolism 59, 967–976 (2010).
   Google Scholar
• Minokoshi Y, Kim YB, Peroni OD et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415, 339–343 (2002).
   Google Scholar
• Watt MJ, Dzamko N, Thomas WG et al. CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK. Nat. Med. 12, 541–548 (2006).
   Google Scholar
• Viollet B, Horman S, Leclerc J et al. AMPK inhibition in health and disease. Crit. Rev. Biochem. Mol. Biol. 45, 276–295 (2010).
   Google Scholar
• Cho KJ, Moon HE, Moini H et al. a-lipoic acid inhibits adipocyte differentiation by regulating pro-adipogenic transcription factors via mitogen-activated protein kinase pathways. J. Biol. Chem. 278, 34823–34833 (2003). Describes, for the first time, the antiadipogenic action of a-LA which could also contribute to its antiobesity properties.
   Google Scholar
• Lee WJ, Song KH, Koh EH et al. a-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle. Biochem. Biophys. Res. Commun. 332, 885–891 (2005).
   Google Scholar
• Park KG, Min AK, Koh EH et al. a-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPKindependent pathways. Hepatology 48, 1477–1486 (2008).
   Google Scholar
• Huong DT, Ide T. Dietary lipoic aciddependent changes in the activity and mRNA levels of hepatic lipogenic enzymes in rats. Br. J. Nutr. 100, 79–87 (2008).
   Google Scholar
• Valdecantos MP, Perez-Matute P, Gonzalez-Muniesa P et al. Lipoic acid improves mitochondrial function in nonalcoholic steatosis through the stimulation of sirtuin 1 and sirtuin 3. Obesity (Silver Spring) 20, 1974–1983 (2012). a-LA prevents hepatic steatosis by improving mitochondrial function through the deacetylation of Foxo3a and PGC1b by SIRT1 and SIRT3.
   Google Scholar
• Jaworski K, Ahmadian M, Duncan RE et al. AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency. Nat. Med. 15, 159–168 (2009).
   Google Scholar
• Reid BN, Ables GP, Otlivanchik OA et al. Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis. J. Biol. Chem. 283, 13087–13099 (2008).
   Google Scholar
• Jocken JW, Blaak EE, Schiffelers S et al. Association of a b-2 adrenoceptor (ADRB2) gene variant with a blunted in vivo lipolysis and fat oxidation. Int. J. Obes. (Lond.) 31, 813–819 (2007).
   Google Scholar
• Huijsman E, van de Par C, Economou C et al. Adipose triacylglycerol lipase deletion alters whole body energy metabolism and impairs exercise performance in mice. Am. J. Physiol. Endocrinol. Metab. 297, e505–e513 (2009).
   Google Scholar
• Ahmadian M, Abbott MJ, Tang T et al. Desnutrin/ATGL is regulated by AMPK and is required for a brown adipose phenotype. Cell Metab. 13, 739–748 (2011).
   Google Scholar
• Hamano Y. Influence of lipoic acid on lipid metabolism and b-adrenergic response to intravenous or oral administration of clenbuterol in broiler chickens. Reprod. Nutr. Dev. 42, 307–316 (2002).
   Google Scholar
• Hamano Y. Effects of dietary lipoic acid on plasma lipid, in vivo insulin sensitivity, metabolic response to corticosterone and in vitro lipolysis in broiler chickens. Br. J. Nutr. 95, 1094–1101 (2006).
   Google Scholar
• Fernandez-Galilea M, Perez-Matute P, Prieto-Hontoria PL, Martinez JA, Moreno-Aliaga MJ. Effects of lipoic acid on lipolysis in 3T3-L1 adipocytes. J. Lipid Res. 53, 2296–2306 (2012). Demonstrated the lipolytic properties of a-LA in adipocytes by the regulation of the activity of main lipases and proteins involved in the lipolytic pathway.
   Google Scholar
• Badin PM, Loubiere C, Coonen M et al. Regulation of skeletal muscle lipolysis and oxidative metabolism by the co-lipase CGI-58. J. Lipid Res. 53, 839–848 (2012).
   Google Scholar
• Kuo YT, Lin TH, Chen WL, Lee HM. a-lipoic acid induces adipose triglyceride lipase expression and decreases intracellular lipid accumulation in HepG2 cells. Eur. J. Pharmacol. 692, 10–18 (2012).
   Google Scholar
• Ormseth MJ, Swift LL, Fazio S et al. Free fatty acids are associated with insulin resistance but not coronary artery atherosclerosis in rheumatoid arthritis. Atherosclerosis 219, 869–874 (2011).
   Google Scholar
• Yang RL, Li W, Shi YH, Le GW. Lipoic acid prevents high-fat diet-induced dyslipidemia and oxidative stress: a microarray analysis. Nutrition 24, 582–588 (2008).
   Google Scholar
• Rong JX, Qiu Y, Hansen MK et al. Adipose mitochondrial biogenesis is suppressed in db/ db and high-fat diet-fed mice and improved by rosiglitazone. Diabetes 56, 1751–1760 (2007).
   Google Scholar
• Hojlund K, Mogensen M, Sahlin K, Beck-Nielsen H. Mitochondrial dysfunction in Type 2 diabetes and obesity. Endocrinol. Metab. Clin. N. Am. 37, 713–731, x (2008).
   Google Scholar
• Shen W, Hao J, Feng Z et al. Lipoamide or lipoic acid stimulates mitochondrial biogenesis in 3T3-L1 adipocytes via the endothelial NO synthase-cGMP-protein kinase G signalling pathway. Br. J. Pharmacol. 162, 1213–1224 (2011).
   Google Scholar
• Eason RC, Archer HE, Akhtar S, Bailey CJ. Lipoic acid increases glucose uptake by skeletal muscles of obese-diabetic ob/ob mice. Diabetes Obes. Metab. 4, 29–35 (2002).
   Google Scholar
• Bitar MS, Wahid S, Pilcher CW, Al-Saleh E, Al-Mulla F. a-lipoic acid mitigates insulin resistance in Goto-Kakizaki rats. Horm. Metab. Res. 36, 542–549 (2004).
   Google Scholar
• Gupte AA, Bomhoff GL, Morris JK, Gorres BK, Geiger PC. Lipoic acid increases heat shock protein expression and inhibits stress kinase activation to improve insulin signaling in skeletal muscle from high-fat-fed rats. J. Appl. Physiol. 106, 1425–1434 (2009).
   Google Scholar
• Estrada DE, Ewart HS, Tsakiridis T et al. Stimulation of glucose uptake by the natural coenzyme a-lipoic acid/thioctic acid: participation of elements of the insulin signaling pathway. Diabetes 45, 1798–1804 (1996).
   Google Scholar
• Dicter N, Madar Z, Tirosh O. a-lipoic acid inhibits glycogen synthesis in rat soleus muscle via its oxidative activity and the uncoupling of mitochondria. J. Nutr. 132, 3001–3006 (2002).
   Google Scholar
• Konrad T, Vicini P, Kusterer K et al. a-lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with Type 2 diabetes. Diabetes Care 22, 280–287 (1999).
   Google Scholar
• Scherer PE. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55, 1537–1545 (2006).
   Google Scholar
• Jung TS, Kim SK, Shin HJ et al. a-lipoic acid prevents non-alcoholic fatty liver disease in OLETF rats. Liver Int. 32, 1565–1573 (2012).
   Google Scholar
• Prieto-Hontoria PL, Perez-Matute P, Fernandez-Galilea M, Martinez JA, Moreno-Aliaga MJ. Lipoic acid inhibits leptin secretion and Sp1 activity in adipocytes. Mol. Nutr. Food Res. 55, 1059–1069 (2011). Describes, for the first time, the ability of a-LA to directly modulate leptin secretion in cultured adipocytes.
   Google Scholar
• Prieto-Hontoria PL, Perez-Matute P, Fernandez-Galilea M, Martinez JA, Moreno-Aliaga MJ. Effects of lipoic acid on AMPK and adiponectin in adipose tissue of low- and high-fat-fed rats. Eur. J. Nutr. 52(2), 779–787 (2013).
   Google Scholar
• Prieto-Hontoria PL, Fernandez-Galilea M, Perez-Matute P, Martinez JA, Moreno-Aliaga MJ. Lipoic acid inhibits adiponectin production in 3T3-L1 adipocytes. J. Physiol. Biochem. doi:10.1007/s13105-012-0230-7 (2013) (Epub ahead of print).
   Google Scholar
• Cavallo MG, Sentinelli F, Barchetta I et al. Altered glucose homeostasis is associated with increased serum apelin levels in Type 2 diabetes mellitus. PLoS ONE 7, e51236 (2012).
   Google Scholar
• Dray C, Knauf C, Daviaud D et al. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab. 8, 437–445 (2008).
   Google Scholar
• Attane C, Foussal C, Le Gonidec S et al. Apelin treatment increases complete fatty acid oxidation, mitochondrial oxidative capacity, and biogenesis in muscle of insulin-resistant mice. Diabetes 61, 310–320 (2012).
   Google Scholar
• Fernandez-Galilea M, Perez-Matute P, Prieto-Hontoria P, Martinez JA, Moreno-Aliaga MJ. Effects of lipoic acid on apelin in 3T3-L1 adipocytes and in high-fat fed rats. J. Physiol. Biochem. 67, 479–486 (2011).
   Google Scholar
• Yu S, Zhang Y, Li MZ et al. Chemerin and apelin are positively correlated with inflammation in obese Type 2 diabetic patients. Chin. Med. J. (Engl.) 125, 3440–3444 (2012).
   Google Scholar
• Padmalayam I, Hasham S, Saxena U, Pillarisetti S. Lipoic acid synthase (LASY): a novel role in inflammation, mitochondrial function, and insulin resistance. Diabetes 58, 600–608 (2009).
   Google Scholar
• Padmalayam I. Targeting mitochondrial oxidative stress through lipoic acid synthase: a novel strategy to manage diabetic cardiovascular disease. Cardiovasc. Hematol. Agents Med. Chem. 10, 223–233 (2012).
   Google Scholar
• Teachey MK, Taylor ZC, Maier T et al. Interactions of conjugated linoleic acid and lipoic acid on insulin action in the obese Zucker rat. Metabolism 52, 1167–1174 (2003).
   Google Scholar
• Shen W, Liu K, Tian C et al. R-a-lipoic acid and acetyl-l-carnitine complementarily promote mitochondrial biogenesis in murine 3T3-L1 adipocytes. Diabetologia 51, 165–174 (2008).
   Google Scholar
• Shen W, Hao J, Tian C et al. A combination of nutriments improves mitochondrial biogenesis and function in skeletal muscle of Type 2 diabetic Goto-Kakizaki rats. PLoS ONE 3, e2328 (2008).
   Google Scholar